Literature DB >> 11097214

Modulation of leukocyte behavior by an inflamed extracellular matrix.

H Schor1, G G Vaday, O Lider.   

Abstract

Inflammation is a response of the immune system to foreign insult or physical damage. Various cellular and humoral components of the immune system are recruited from the vascular system and are translocated through endothelium, and into extracellular matrix (ECM) compartments of inflamed tissues. This translocation is orchestrated by various types of accessory signals, in the form of soluble or complexed molecules, which evoke remarkable transitions in leukocyte activities. Recruited inflammatory cells give rise to mechanisms of migration, including the secretion of enzymes and other pro-inflammatory mediators and the alteration of their adhesive contacts with the ECM. Hence, migrating cells secrete enzymes, chemokines, and cytokines which interact with the ECM, and thereby, provide the cells with intrinsic signals for coordinating their responses. Resultant products of enzymatic modifications to the ECM microenvironment, such as cytokine- and ECM-derived molecules, may be also part of a cell-signaling mechanism that provides leukocytes with information about the nature of their inflammatory activity; such a mechanism may give the immune system data that can be cognitively interpreted for consequential activities. This article reviews the findings that support this notion and describe the dynamic interactions between participants of the inflammatory processes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11097214      PMCID: PMC2276059          DOI: 10.1155/2000/51902

Source DB:  PubMed          Journal:  Dev Immunol        ISSN: 1026-7905


  19 in total

1.  HIF-1alpha is essential for myeloid cell-mediated inflammation.

Authors:  Thorsten Cramer; Yuji Yamanishi; Björn E Clausen; Irmgard Förster; Rafal Pawlinski; Nigel Mackman; Volker H Haase; Rudolf Jaenisch; Maripat Corr; Victor Nizet; Gary S Firestein; Hans Peter Gerber; Napoleone Ferrara; Randall S Johnson
Journal:  Cell       Date:  2003-03-07       Impact factor: 41.582

Review 2.  Proteoglycans: key regulators of pulmonary inflammation and the innate immune response to lung infection.

Authors:  Sean Gill; Thomas N Wight; Charles W Frevert
Journal:  Anat Rec (Hoboken)       Date:  2010-06       Impact factor: 2.064

Review 3.  Intact extracellular matrix and the maintenance of immune tolerance: high molecular weight hyaluronan promotes persistence of induced CD4+CD25+ regulatory T cells.

Authors:  Paul L Bollyky; Ben A Falk; Rebecca P Wu; Jane H Buckner; Thomas N Wight; Gerald T Nepom
Journal:  J Leukoc Biol       Date:  2009-04-28       Impact factor: 4.962

Review 4.  Interplay of extracellular matrix and leukocytes in lung inflammation.

Authors:  Thomas N Wight; Charles W Frevert; Jason S Debley; Stephen R Reeves; William C Parks; Steven F Ziegler
Journal:  Cell Immunol       Date:  2016-12-23       Impact factor: 4.868

Review 5.  Versican and the regulation of cell phenotype in disease.

Authors:  Thomas N Wight; Michael G Kinsella; Stephen P Evanko; Susan Potter-Perigo; Mervyn J Merrilees
Journal:  Biochim Biophys Acta       Date:  2014-01-05

Review 6.  Versican and Versican-matrikines in Cancer Progression, Inflammation, and Immunity.

Authors:  Athanasios Papadas; Garrett Arauz; Alexander Cicala; Joshua Wiesner; Fotis Asimakopoulos
Journal:  J Histochem Cytochem       Date:  2020-07-06       Impact factor: 2.479

Review 7.  Interdependence of hypoxic and innate immune responses.

Authors:  Victor Nizet; Randall S Johnson
Journal:  Nat Rev Immunol       Date:  2009-09       Impact factor: 53.106

Review 8.  Hypoxia inducible factor (HIF) function in innate immunity and infection.

Authors:  Annelies S Zinkernagel; Randall S Johnson; Victor Nizet
Journal:  J Mol Med (Berl)       Date:  2007-11-21       Impact factor: 4.599

Review 9.  Intestinal fibrosis in IBD--a dynamic, multifactorial process.

Authors:  Florian Rieder; Claudio Fiocchi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-04       Impact factor: 46.802

Review 10.  Versican and the control of inflammation.

Authors:  Thomas N Wight; Inkyung Kang; Mervyn J Merrilees
Journal:  Matrix Biol       Date:  2014-02-07       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.